Trial Profile
A phase II study of ARA 290 as therapeutic strategy in rheumatoid arthritis.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Cibinetide (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ARARA
- 16 Nov 2010 New trial record